World's Best Scientists 2026 revealed!
Gianpietro Semenzato

Gianpietro Semenzato

D-Index & Metrics

Immunology

D-Index
80
Citations
25121
World Ranking
1617
National Ranking
63

Medicine

D-Index
80
Citations
25130
World Ranking
17046
National Ranking
682

Gianpietro Semenzato publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gianpietro Semenzato sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 690 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gianpietro Semenzato D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gianpietro Semenzato sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 80 D-Index — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gianpietro Semenzato is affiliated with the University of Padua in Italy. Their research spans primarily the field of Medicine, with a significant focus on Genetics, Hematology, Pathology and Forensic Medicine, Immunology, and Oncology.

The main topics covered in their work include:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Multiple Myeloma Research and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Immune Cell Function and Interaction
  • Acute Myeloid Leukemia Research

Frequent co-authors collaborating with Semenzato include:

  • Renato Zambello
  • Livio Trentin
  • Antonella Teramo
  • Gregorio Barilà
  • Giulia Calabretto

They have published extensively in several venues, with notable publication counts in:

  • Blood
  • HemaSphere
  • Blood Cancer Journal
  • Frontiers in Oncology
  • Cancers

Recent papers authored by Semenzato and colleagues include:

  • Genomic profiling for clinical decision making in lymphoid neoplasms, 2022, Blood
  • Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis, 2021, Blood Cancer Journal
  • Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study, 2020, The Lancet Haematology
  • Insights Into Genetic Landscape of Large Granular Lymphocyte Leukemia, 2020, Frontiers in Oncology
  • The complex karyotype landscape in chronic lymphocytic leukemia allows the refinement of the risk of Richter syndrome transformation, 2021, Haematologica

Best Publications

  • ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders.

    Hunninghake Gw;Costabel U;Ando M;Baughman R

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis

    Marco Chilosi;Venerino Poletti;Alberto Zamò;Maurizio Lestani

  • The Lymphoproliferative Disease of Granular Lymphocytes: Updated Criteria for Diagnosis

    Gianpietro Semenzato;Renato Zambello;Gordon Starkebaum;Kazuo Oshimi

  • Sarcoidosis is a Th1/Th17 multisystem disorder

    Monica Facco;Anna Cabrelle;Antonella Teramo;Valeria Olivieri

  • Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis

    Antonella Contri;Anna Maria Brunati;Livio Trentin;Anna Cabrelle

  • Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells.

    Lucia Olcese;Anna Cambiaggi;Gianpietro Semenzato;Cristina Bottino

  • Identification of NKp80, a novel triggering molecule expressed by human NK cells.

    Massimo Vitale;Michela Falco;Roberta Castriconi;Silvia Parolini

  • Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection

    Carlo Agostini;Fiorella Calabrese;Federico Rea;Monica Facco

  • Abnormal Re-epithelialization and Lung Remodeling in Idiopathic Pulmonary Fibrosis: The Role of ΔN-p63

    Marco Chilosi;Venerino Poletti;Bruno Murer;Maurizio Lestani

  • Combination of Rituximab, Bendamustine, and Cytarabine for Patients With Mantle-Cell Non-Hodgkin Lymphoma Ineligible for Intensive Regimens or Autologous Transplantation

    Carlo Visco;Silvia Finotto;Renato Zambello;Rossella Paolini

  • Involvement of the IP-10 Chemokine in Sarcoid Granulomatous Reactions

    Carlo Agostini;Marco Cassatella;Renato Zambello;Livio Trentin

  • Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases

    Renzo Marcolongo;Ivan Matteo Tavolini;Francesco Laveder;Moira Busa

  • ROLE OF IL-15, IL-2 AND THEIR RECEPTORS IN THE DEVELOPMENT OF T CELL ALVEOLITIS IN PULMONARY SARCOIDOSIS

    C Agostini;L Trentin;M Facco;R Sancetta

  • The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions

    G. Semenzato;F. Pandolfi;T. Chisesi;G. De Rossi

  • Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms.

    Unknown

  • Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo.

    Lars Rogge;Alberto Papi;David H. Presky;Mauro Biffi

  • THE CHEMOKINE RECEPTOR CXCR3 IS EXPRESSED ON MALIGNANT B CELLS AND MEDIATES CHEMOTAXIS

    Livio Trentin;Carlo Agostini;Monica Facco;Francesco Piazza

  • Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas

    Livio Trentin;Anna Cabrelle;Monica Facco;Davide Carollo

  • New pathogenetic insights into the sarcoid granuloma.

    Carlo Agostini;Fausto Adami;Gianpietro Semenzato

  • Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study.

    F. Pandolfi;T. P. Loughran;G. Starkebaum;T. Chisesi

  • A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation.

    Cristina Bottino;Simona Sivori;Massimo Vitale;Claudia Cantoni

Frequent Co-Authors

Livio Trentin
Livio Trentin University of Padua
Carlo Agostini
Carlo Agostini University of Padua
Giovanni Pizzolo
Giovanni Pizzolo University of Verona
Marco Chilosi
Marco Chilosi University of Verona
Michele Cavo
Michele Cavo University of Bologna
Francesco Di Raimondo
Francesco Di Raimondo University of Catania
Robin Foà
Robin Foà Sapienza University of Rome
Anna Maria Brunati
Anna Maria Brunati University of Padua
Andrea Cerutti
Andrea Cerutti Icahn School of Medicine at Mount Sinai
Alessandro Moretta
Alessandro Moretta University of Genoa

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology can open doors to diverse healthcare roles, especially when combined with nursing expertise. Many professionals consider enhancing their qualifications through specialized programs such as accelerated nurse practitioner tracks. For instance, exploring accelerated FNP programs can provide a faster route to becoming a Family Nurse Practitioner with advanced clinical skills.

Those currently working as Family Nurse Practitioners might be interested in transitioning to more specialized roles. Insights into the FNP to Acute Care NP bridge program offer guidance on upgrading skills for acute care settings, which can be highly relevant when focusing on immunological disorders and treatments.

For those without a nursing background, there are pathways available to enter the field. Programs such as online RN programs for non nurses in Florida provide flexible options to acquire foundational nursing credentials needed for advanced study and practice.

Salary prospects also vary significantly by location. Understanding DNP salary by state can help prospective students and professionals make informed decisions about where to study and work, aligning career goals with financial considerations.

Best Scientists Citing Gianpietro Semenzato

Trending Scientists

Recently Published Articles